# A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions

> **NCT00773630** · PHASE1 · COMPLETED · sponsor: **Otsuka Frankfurt Research Institute GmbH** · enrollment: 44 (actual)

## Conditions studied

- Intermittent Claudication

## Interventions

- **DRUG:** Cilostazol

## Key facts

- **NCT ID:** NCT00773630
- **Lead sponsor:** Otsuka Frankfurt Research Institute GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2011-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00773630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00773630, "A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00773630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*